Dr. Yan Zhang Receives Supplement
August 25, 2020
Congratulations to Dr. Yan Zhang who has been awarded a supplement titled ' Novel fentanyl derivatives as counteracting agents against fentanyl'. Thisfurthers his current UG3 grant ' Mu Opioid Receptor Modulator Development to Treat Opioid Use Disorder' from NIDA. UG3 mechanism is an early phase exploratory cooperative agreement to assess clinical promise of novel agents.